BOLA3 Antibody (PCRP-BOLA3-1A5) [DyLight 650]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-20915C
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Human
Applications
Flow Cytometry, Immunoprecipitation
Label
DyLight 650 (Excitation = 652 nm, Emission = 672 nm)
Antibody Source
Monoclonal Mouse IgG1 Clone # PCRP-BOLA3-1A5
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Specifications
Immunogen
Recombinant fragment (around aa1-103) of human BOLA3 protein (exact sequence is proprietary)
Localization
Nucleus. Associated with nuclear bodies. Mitochondria.
Clonality
Monoclonal
Host
Mouse
Isotype
IgG1
Applications for BOLA3 Antibody (PCRP-BOLA3-1A5) [DyLight 650]
Application
Recommended Usage
Flow Cytometry
Optimal dilutions of this antibody should be experimentally determined.
Immunoprecipitation
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A or G purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: BOLA3
Alternate Names
bolA homolog 3 (E. coli), bolA-like 3, bolA-like protein 3
Gene Symbol
BOLA3
Additional BOLA3 Products
Product Documents for BOLA3 Antibody (PCRP-BOLA3-1A5) [DyLight 650]
Product Specific Notices for BOLA3 Antibody (PCRP-BOLA3-1A5) [DyLight 650]
DyLight (R) is a trademark of Thermo Fisher Scientific Inc. and its subsidiaries.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...